Horizon 2020 (2014 - 2020)

Commercial feasibility assessment of the first single-photon detector for CT

Last update: May 12, 2022 Last update: May 12, 2022

Details

Locations:Switzerland
Start Date:Apr 1, 2018
End Date:Mar 31, 2019
Contract value:EUR 150,000
Sectors:Science & InnovationScience & Innovation
Categories:Grants
Date posted:May 12, 2022

Associated funding

Associated experts

Description

Programme(s): H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Topic(s): ERC-2017-PoC - ERC-Proof of Concept

Call for proposal: ERC-2017-PoC

Funding Scheme: ERC-POC - Proof of Concept Grant

Grant agreement ID: 790341

Objective: The reduction of radiation exposure in Computed Tomography (CT) remains a pressing medical need in radiology and a major growth opportunity for the medical imaging industry. As part of our ERC research, we have identified a novel method to produce crystalline, photo-sensitive nanowires. These nanowires show a remarkable sensitivity, nearing single-photon detection; about 100 times better than current detectors. This could cause a seismic shift in medical imaging as it will drastically increase the safety of CT and open up many new applications for CT as a modality.
In this project, we will assess the commercial feasibility of this novel detector. As part of this study we will investigate the scalability of our technology and characteristics of the market and will develop and implement a sound business strategy.

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.